A win for neurology patients seeking answers
Neurology patients have greater access to new therapies following the opening of a new clinical trials facility at The Alfred - part of a innovative partnership with Monash University.
Federal Health Minister Greg Hunt, Parliamentary Secretary for Medical Research Frank McGuire, and Member for Tarneit Telmo Languiller visited the facility on the neurology ward today.
The Alfred is now the only hospital in Australia with the capability to offer and test the most innovative new treatments and therapies in neurology – all in the safety of our ward setting.
Professor Terry O’Brien, Director of Alfred Brain and Head of the Monash University Department of Neurosciences, said this is the first facility in Australia that allows patients to receive neurological care while getting access to ‘first-in-disease’ treatment.
“Because the unit is embedded within the neurology ward, it allows patients with a variety of neurological diseases to be admitted, trial new drugs, and receive intensive 24-hour monitoring and the care they need. New treatments will be tested here first," Prof O'Brien said.
More than 20 clinical trials are already underway covering epilepsy, cluster headaches, multiple sclerosis, stroke, Alzheimer’s Disease, Parkinson’s Disease, progressive supranuclear palsy and concussion.
The new department includes Monash’s new basic neurosciences laboratory and pre-clinical imaging facility.